NASDAQ:EDIT 2 November 2025 - 4 June 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

CRISPR Therapeutics Jumps 12% in New York Trading

CRISPR Therapeutics AG shares surged in early afternoon U.S. trade Thursday, up 11.7% at $58.15. Investors moved into gene-editing stocks. The Nasdaq name hit an intraday high of $59.00. About 2.0 million shares traded, putting its market cap close to $5.6 billion.

4 June 2026

Biotechnology·NASDAQ:BEAM·NASDAQ:CRSP·NASDAQ:EDIT·NASDAQ:NTLA·NASDAQ:VRTX·NYSE:LLY·Stock Market

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics AG shares slid on Friday, bucking a firmer broader market, after a regulatory filing flagged a chief financial officer’s share sale under a pre-arranged trading plan.

9 January 2026

Biotechnology·NASDAQ:BEAM·NASDAQ:CRSP·NASDAQ:EDIT·NASDAQ:NTLA·NASDAQ:VRTX·Pharmaceuticals·Stock Market

CRISPR Therapeutics stock (CRSP) slips into 2026 as New Year’s Day shuts Wall Street — what investors watch next

Shares of CRISPR Therapeutics AG ended the last trading session of 2025 down 1.4% at $52.44. U.S. stock markets were closed on Thursday for New Year’s Day, according to the NYSE holiday calendar. StockAnalysis+1

2 January 2026

Biotechnology·NASDAQ:BEAM·NASDAQ:CRSP·NASDAQ:EDIT·NASDAQ:NTLA·NASDAQ:VRTX·Stock Market

Premarket Shock: Why CRISPR Therapeutics Could Move Big Today

CRSP is trading around the mid-$60s ahead of Monday’s open. By Reuters it was ~$64.04 Reuters. Over the past month CRSP has gained roughly 17% Genengnews, boosted by recent data releases. For example, a 3-day rally in mid-Oct lifted CRSP ~5% after the SyNTase/CTX460 results were announced Genengnews.

2 November 2025

Biotechnology·LSE:AZN·NASDAQ:BEAM·NASDAQ:CRSP·NASDAQ:EDIT·NASDAQ:NTLA·Stock Market

Go toTop